Tofacitinib Tied to RA Symptom Improvements and Blood Changes Over the Long Term Tofacitinib Tied to RA Symptom Improvements and Blood Changes Over the Long Term

Over several years of use in rheumatoid arthritis (RA) patients, the oral Janus kinase inhibitor tofacitinib is associated with reductions in fatigue and improvements in vitality, as well as hematological changes, according to an industry-funded study.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Rheumatology News Source Type: news